Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Semi-Automatic Magnetic Resonance Imaging Annotation Algorithm Based on Semi-Weakly Supervised Learning. | Sensors (Basel) | 2024 | 38931677 | PubTator, text mining | PubMed |
| Therapeutic effect of selective interleukin-2-inducible tyrosine kinase inhibitor in orbital fibroblasts from patients with Graves' orbitopathy. | Endocr J | 2024 | 38866492 | PubTator, text mining | PubMed |
| Identification of potential biomarkers of leprosy: A study based on GEO datasets. | PLoS One | 2024 | 38739634 | PubTator, text mining | PubMed |
| Percées dans la prise en charge de l’hypernéphrome. | CMAJ | 2024 | 38719217 | PubTator, text mining | PubMed |
| Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refractory Hodgkin Lymphoma. | Clin Lymphoma Myeloma Leuk | 2024 | 38693037 | PubTator, text mining | PubMed |
| Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy. | Signal Transduct Target Ther | 2024 | 38688914 | PubTator, text mining | PubMed |
| TNF-α signals through ITK-Akt-mTOR to drive CD4+ T cell metabolic reprogramming, which is dysregulated in rheumatoid arthritis. | Sci Signal | 2024 | 38652761 | PubTator, text mining | PubMed |
| Primary immune regulatory disorders (PIRD): expanding the mutation spectrum in Turkey and identification of sixteen novel variants. | Immunol Res | 2024 | 38644452 | PubTator, text mining | PubMed |
| [L-DEP regimen salvage therapy for refractory primary hemophagocytic lymphohistiocytosis triggered by Epstein-Barr virus infection in 4 children]. | Zhonghua Er Ke Za Zhi | 2024 | 38623016 | PubTator, text mining | PubMed |
| Major breakthroughs in hematopoietic stem cell transplantation and future challenges in clinical implementation. | J Clin Invest | 2024 | 38618950 | PubTator, text mining | PubMed |
| Interaction of T-cell-specific adapter protein with Src- and Tec-family kinases. | Scand J Immunol | 2024 | 38605535 | PubTator, text mining | PubMed |
| Screening of potential biomarkers in propofol-induced neurotoxicity via bioinformatics prediction and experimental verification. | Am J Transl Res | 2024 | 38586100 | PubTator, text mining | PubMed |
| DeepN4: Learning N4ITK Bias Field Correction for T1-weighted Images. | Neuroinformatics | 2024 | 38526701 | PubTator, text mining | PubMed |
| Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary Cancer. | Int J Mol Sci | 2024 | 38396726 | PubTator, text mining | PubMed |
| scCASE: accurate and interpretable enhancement for single-cell chromatin accessibility sequencing data. | Nat Commun | 2024 | 38388573 | PubTator, text mining | PubMed |
| Role of Signal-Transducing Adaptor Protein-1 for T Cell Activation and Pathogenesis of Autoimmune Demyelination and Airway Inflammation. | J Immunol | 2024 | 38315039 | PubTator, text mining | PubMed |
| Successful management of acute graft-versus-host disease with ibrutinib during cord blood transplantation for germline DDX41-mutated acute myeloid leukemia. | Heliyon | 2024 | 38312561 | PubTator, text mining | PubMed |
| Tonsillar cytotoxic CD4 T cells are involved in the control of EBV primary infection in children. | Sci Rep | 2024 | 38273012 | PubTator, text mining | PubMed |
| Sialidase NEU3 Contributes to the Invasiveness of Bladder Cancer. | Biomedicines | 2024 | 38255300 | PubTator, text mining | PubMed |
| Adaptive immune cells are necessary for SARS-CoV-2-induced pathology. | Sci Adv | 2024 | 38170764 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=7